Family Medicine Doctors in Owenton, KY Accepting Medicare
3 Family Medicine doctors found. Showing 1 - 3
 Mr. Larry C Johnson, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 120 Progress Way, Owenton, KY 40359 Phone: 844-655-6100 Fax: 502-484-2102 |
Mr. Eric C. Baumann, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 120 Progress Way, Owenton, KY 40359 Phone: 844-655-6100 Fax: 502-484-2102 |
Mr. Douglas M Smalara, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 120 Progress Way, Owenton, KY 40359 Phone: 844-655-6100 Fax: 502-484-2102 |
News Archive
New poll reveals U.S. public's perceptions of causes of health problems
A new NPR/Robert Wood Johnson Foundation/Harvard T.H. Chan School of Public Health poll finds that more than six in ten people living in the U.S. (62%) are concerned about their future health. Nearly four in ten (39%) said that they had one or more negative childhood experiences that they believe had a harmful impact on their adult health.
Oxytocin may inhibit social phobia
Swedish and British scientists have shown using functional magnetic resonance imaging (fMRI) that the hormone oxytocin can inhibit feelings of anxiety in specific individuals. Their discovery might lead to a better understanding and the improved treatment of psychiatric affections in which people feel distressed when meeting others, such as in cases of autism and social phobia.
ACTIV group assesses controlled human infection models for developing SARS-CoV-2 vaccine
In a Perspective for the New England Journal of Medicine, members of the National Institutes of Health's Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Vaccines Working Group assess practical considerations and prerequisites for using controlled human infection models (CHIMs), which can be used for human challenge studies, to support SARS-CoV-2 vaccine development.
Leading experts to promote cardiovascular health at EuroPrevent 2018
The impact of nutrition and lifestyle on cardiovascular health will be key elements discussed by health professionals during EuroPrevent 2018 in Ljubljana, Slovenia, in April. EuroPrevent is the annual congress of the European Association of Preventive Cardiology, a branch of the European Society of Cardiology.
Daiichi Sankyo, Plexxikon's Phase 1 trial shows PLX3397 induced prolonged tumor regression in TGCT patients
Daiichi Sankyo Europe and Plexxikon Inc., a member of the Daiichi Sankyo Group, announced today that The New England Journal of Medicine published clinical trial results demonstrating that the investigational drug, PLX3397, an oral targeted CSF-1R inhibitor, induced prolonged tumor regressions in most patients with tenosynovial giant cell tumor, a rare, locally aggressive neoplasm of the joint or tendon sheath.
› Verified 6 days ago